
Palatin Technologies, Inc.
AMEX:PTN
1.92 (USD) • At close November 27, 2023
Overzicht | Financiële gegevens
Bedrijfsnaam | Palatin Technologies, Inc. |
Symbool | PTN |
Munteenheid | USD |
Prijs | 1.96 |
Beurswaarde | 26,018,216 |
Dividendpercentage | 0% |
52-weken bereik | 1.43 - 5 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Dr. Carl Spana Ph.D. |
Website | https://palatin.com |
An error occurred while fetching data.
Over Palatin Technologies, Inc.
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)